Insilico's anti-aging drug Rentosertib dosed first Phase III patient, synthesized with fly-brain compute
Scobleizer · x · 2026-09-12
Insilico Medicine announced the first patient dosed in a Phase III trial of Rentosertib, its anti-aging drug candidate. The team says the compound was synthesized with help from its insilicoSOTA foundation models, playfully framing it as training a fly brain to do medicinal chemistry.
More from Research
- CodeFinetuner: fine-tune a local code autocomplete model on your own codebase — MountainTop321 · 2026-09-12
- Persistent-memory denoiser hits 99.9% on Sudoku-Extreme with under 250k parameters — LucaAmb · 2026-09-12
- MIT's Astra invents its own scientific instruments, finds metamaterial 2.1x stronger than reference — ProfBuehlerMIT · 2026-09-12
- GPT-6 fails to improve on molecular property prediction, fueling AGI skepticism — GaryMarcus · 2026-09-12
- Fruit fly brain connectome simulated to play Beat Saber, startling researchers — LinusEkenstam · 2026-09-12
- Fruit fly connectome plays chess at ~700 Elo in playable online demo — dejavucoder · 2026-09-12